NO854461L - Fremgangsmaate for aa opploeseliggjoere organiske forbindelser. - Google Patents

Fremgangsmaate for aa opploeseliggjoere organiske forbindelser.

Info

Publication number
NO854461L
NO854461L NO854461A NO854461A NO854461L NO 854461 L NO854461 L NO 854461L NO 854461 A NO854461 A NO 854461A NO 854461 A NO854461 A NO 854461A NO 854461 L NO854461 L NO 854461L
Authority
NO
Norway
Prior art keywords
organic compounds
procedure
determining organic
aqueous
mucous
Prior art date
Application number
NO854461A
Other languages
English (en)
Other versions
NO165626B (no
NO165626C (no
Inventor
Jerome Corbiere
Original Assignee
Jerome Corbiere
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jerome Corbiere filed Critical Jerome Corbiere
Publication of NO854461L publication Critical patent/NO854461L/no
Publication of NO165626B publication Critical patent/NO165626B/no
Publication of NO165626C publication Critical patent/NO165626C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
NO85854461A 1984-03-14 1985-11-08 Fremgangsmaate for aa opploeseliggjoere en hydrofob, terapeutisk aktiv, organisk forbindelse, spesielt en n-acyl-indol. NO165626C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH127984 1984-03-14
PCT/FR1985/000050 WO1985004106A1 (fr) 1984-03-14 1985-03-12 Ppocede de solubilisation de principes actifs et compositions pharmaceutiques ainsi obtenues

Publications (3)

Publication Number Publication Date
NO854461L true NO854461L (no) 1985-11-08
NO165626B NO165626B (no) 1990-12-03
NO165626C NO165626C (no) 1991-03-13

Family

ID=4206704

Family Applications (1)

Application Number Title Priority Date Filing Date
NO85854461A NO165626C (no) 1984-03-14 1985-11-08 Fremgangsmaate for aa opploeseliggjoere en hydrofob, terapeutisk aktiv, organisk forbindelse, spesielt en n-acyl-indol.

Country Status (12)

Country Link
US (1) US4794117A (no)
EP (1) EP0173729B1 (no)
JP (1) JPS61501566A (no)
KR (1) KR930000029B1 (no)
AT (1) ATE57472T1 (no)
AU (1) AU573321B2 (no)
DE (1) DE3580140D1 (no)
HU (1) HU195918B (no)
IT (1) IT1200410B (no)
NO (1) NO165626C (no)
OA (1) OA08170A (no)
WO (1) WO1985004106A1 (no)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8607662D0 (en) * 1986-03-27 1986-04-30 Rainsford K D Pharmaceutical formulation
US5071643A (en) * 1986-10-17 1991-12-10 R. P. Scherer Corporation Solvent system enhancing the solubility of pharmaceuticals for encapsulation
US5110493A (en) * 1987-09-11 1992-05-05 Syntex (U.S.A.) Inc. Ophthalmic NSAID formulations containing a quaternary ammonium preservative and a nonionic surfactant
EP0306984B1 (en) * 1987-09-11 1992-04-15 Syntex (U.S.A.) Inc. Preservative system for ophtalmic formulations
JPH0723302B1 (no) * 1989-08-03 1995-03-15
US5290774A (en) * 1989-08-03 1994-03-01 Eisai Co., Ltd. Photostabilizing method for ophthalmic solutions and the resulting ophthalmic solutions therefrom
DE4342907A1 (de) * 1993-12-16 1995-06-22 Bayer Ag Neue cyclische Depsipeptide mit 18 Ringatomen und ihre Verwendung zur Bekämpfung von Endoparasiten
DK0778775T3 (da) * 1994-09-01 1999-09-13 Upjohn Co Parenteral tirilazad-præparat med coopløsningsmiddel
US6274592B1 (en) * 1997-02-04 2001-08-14 Senju Pharmaceutical Co., Ltd. Method for stabilizing arylcarboxylic acid, stabilizer thereof and aqueous solution containing stabilized arylcarboxylic acid
US6045815A (en) * 1997-08-15 2000-04-04 Board Of Regents, The University Of Texas System Parenteral pimaricin as treatment of systemic infections
US6844004B2 (en) * 1997-08-15 2005-01-18 Board Of Regents, The University Of Texas System Topical formulations of natamycin/pimaricin
US20020035107A1 (en) 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
DE10030345A1 (de) * 2000-06-20 2002-01-10 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen
US6387400B1 (en) 2000-08-29 2002-05-14 R.P. Scherer Technologies, Inc. Process for preparing pharmaceutical compositions for use with soft gelatin formulations
ITMI20012135A1 (it) 2001-10-16 2003-04-16 Bioren S A Soluzioni iniettabili pronte all'uso di paracetamolo
DE10161077A1 (de) 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
US8992980B2 (en) * 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
FR2851164B1 (fr) 2003-02-14 2005-04-22 Xuan Tho Nguyen Formulation liquide injectable de paracetamol
EP1568369A1 (en) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
DE102004021281A1 (de) * 2004-04-29 2005-11-24 Boehringer Ingelheim Vetmedica Gmbh Verwendung von Meloxicam-Formulierungen in der Veterinärmedizin
DE102004030409A1 (de) * 2004-06-23 2006-01-26 Boehringer Ingelheim Vetmedica Gmbh Neue Verwendung von Meloxicam in der Veterinärmedizin
WO2007039417A1 (en) * 2005-09-30 2007-04-12 Boehringer Ingelheim Vetmedica Gmbh Pharmaceutical preparation containing meloxicam
US8497303B2 (en) * 2008-01-18 2013-07-30 Dow Global Technologies Llc Method to enhance aqueous solubility of poorly soluble actives
KR20110116194A (ko) 2009-02-03 2011-10-25 선스타 가부시키가이샤 헤스페리딘 함유 조성물
EP4378443A2 (en) 2009-10-12 2024-06-05 Boehringer Ingelheim Vetmedica GmbH Containers for compositions comprising meloxicam
US20110218191A1 (en) * 2010-03-03 2011-09-08 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the long term-treatment of kidney disorders in cats
US9149480B2 (en) 2010-03-03 2015-10-06 Boehringer Ingeleheim Vetmedica GmbH Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
MX2013000578A (es) * 2010-07-21 2013-02-21 Alcon Res Ltd Composicion farmaceutica con caracteristicas de solubilidad incrementadas.
GB201321743D0 (en) * 2013-12-09 2014-01-22 Ucb Pharma Sa Therapeutic agents

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1916432A1 (de) * 1969-03-31 1970-10-08 Dresden Arzneimittel Verfahren zur Herstellung von Injektionsloesungen von therapeutisch wertvollen Benzodiazepinderivaten und ihren Kombinationen mit anderen Wirkstoffen
IL33774A0 (en) * 1970-01-26 1970-03-22 Abic Ltd A water-soluble composition comprising sulfadimidine and pyrimethamine
DK138974B (da) * 1974-02-19 1978-11-27 Ciba Geigy Ag Fremgangsmåde til fremstilling af vandige oxytetracyclinopløsninger til parenteral, peroral og lokal anvendelse.
DE3006024C2 (de) * 1980-02-18 1983-08-04 Solvon Arzneimittel-Vertriebs- Und Lizenzgesellschaft Mbh, 85011 Burgthann Topisches, Indomethacin enthaltendes Arzneimittel in Salbenform

Also Published As

Publication number Publication date
KR850700216A (ko) 1985-12-26
DE3580140D1 (de) 1990-11-22
KR930000029B1 (ko) 1993-01-06
ATE57472T1 (de) 1990-11-15
AU573321B2 (en) 1988-06-02
EP0173729A1 (fr) 1986-03-12
US4794117A (en) 1988-12-27
IT1200410B (it) 1989-01-18
OA08170A (fr) 1987-03-31
AU4064585A (en) 1985-10-11
HU195918B (en) 1988-08-29
JPS61501566A (ja) 1986-07-31
HUT38263A (en) 1986-05-28
NO165626B (no) 1990-12-03
IT8519873A0 (it) 1985-03-13
EP0173729B1 (fr) 1990-10-17
NO165626C (no) 1991-03-13
WO1985004106A1 (fr) 1985-09-26

Similar Documents

Publication Publication Date Title
NO854461L (no) Fremgangsmaate for aa opploeseliggjoere organiske forbindelser.
NO177004C (no) Analogifremgangsmåte for fremstilling av 7-substituerte derivater av 3,5-dihydroksyhept-6-ynsyre
NO885213D0 (no) Stabiliserte legemidler, fremgangsmŸte til deres fremstilling samt stabile legemiddeltilberedninger.
DK0580817T3 (da) Farmaceutisk præparat og fremgangsmåde til fremstilling deraf
NO871295D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater.
DK644388A (da) Farmaceutiske praeparater indeholdende 3-hydroxy-smoeresyrederivater
ES2032905T3 (es) Sistema terapeutico transcutaneo.
DK0388956T3 (da) Phtalinidderivat, farmaceutisk præparat og anvendelse
NO812556L (no) Fremgangsmaate for stabilisering av tienopyridinderivater
KR880009018A (ko) 3-l-피로글루타밀-l-티아졸리딘-4-카르복실산 및 이의 제법
FR2598081B1 (fr) Procede de preparation d'une solution pharmaceutique aqueuse d'un principe actif constitue par un acide organique
KR890006644A (ko) 결정성 β-락탐 수화물
MA21122A1 (fr) Procede de preparation de derives d'acides aminocarboxyliques bicycliques .
FR2407928A1 (fr) Derives de quinazoline utiles comme medicaments antihypertenseurs et procede de leur preparation
ES502654A0 (es) Un procedimiento para la preparacion de nuevos derivados de 2-propanol
DE3676335D1 (de) Auf mercaptoethansulfonsaeuren basierende pharmazeutische zusammensetzungen, organische abkoemmlinge von mercaptoethansulfonsaeuren sowie verfahren zu deren herstellung.
ES8601149A1 (es) Procedimiento para preparar un ester de metronidazol.
DK0380038T3 (da) 3-Phenyl-5,6-dihydrobenz(c)acridin-7-carboxylsyrer og beslægtede forbindelser som kemoterapeutiske midler mod cancer
NO873514D0 (no) Fremgangsmaate for fremstilling av farmasoeytisk aktive forbindelser.
IT1228437B (it) "derivati di 2,3,4,5,6,7 esaidro 2,7-metano-1,5 benzossazonina (rispettivamente 1,4 benzossazonina), procedimento per la loro preparazione e prodotti medicinali che contengono questi composti.
FI885638A (fi) Menetelmä lääkeaineina käyttökelpoisten griseoliinihappomonoesterijohdannaisten valmistamiseksi
ES526273A0 (es) Procedimiento de fabricacion de un compuesto farmacologico termicamente estable, de dihidrato de oxido amitriptilino
NO864475D0 (no) Cefalosporinderivater og fremgangsmaate til deres fremstilling.
NO171726C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3((1,2,3-tiadiazol-4-yl)tiometyl)-8-okso-5-tia-1-azabicyklo(4.2.0)okt-2-en-2-karboksylsyrederivater
IT8747522A0 (it) Derivati di acidi nucleici, fisiolo gicamente attivi, utili come composti farmaceutici